scispace - formally typeset
D

David M. Vail

Researcher at University of Wisconsin-Madison

Publications -  154
Citations -  7295

David M. Vail is an academic researcher from University of Wisconsin-Madison. The author has contributed to research in topics: Cancer & Chemotherapy. The author has an hindex of 47, co-authored 152 publications receiving 6417 citations.

Papers
More filters
Book

Withrow & Macewen's Small Animal Clinical Oncology

TL;DR: Why worry about cancer in companion animals?
Journal ArticleDOI

Response evaluation criteria for solid tumours in dogs (v1.0): a Veterinary Cooperative Oncology Group (VCOG) consensus document

TL;DR: The human response evaluation criteria in solid tumours is used as a framework to establish standard procedures for response assessment in canine solid tumour assessment that is meant to be easy to use, repeatable and applicable across a variety of clinical trial structures in veterinary oncology.
Journal ArticleDOI

Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0)--a Veterinary Cooperative Oncology Group (VCOG) consensus document.

TL;DR: These guidelines are intended only for use in dogs, where peripheral lymphadenopathy represents the principal component of their disease and as such do not critically assess extranodal disease (e.g., primary cutaneous, central nervous system, gastrointestinal).
Journal ArticleDOI

Feline Lymphoma (145 Cases): Proliferation Indices, Cluster of Differentiation 3 Immunoreactivity, and Their Association with Prognosis in 90 Cats

TL;DR: Paraffin-embedded, formalin-fixed tissue samples from 145 cats with lymphoma were analyzed for cluster of differentiation 3 (CD3, a surface antigen) immunoreactivity, argyrophilic nucleolar organizer region (AgNOR) frequency, and proliferating cell nuclear antigen labeling index (PCNA-LI) to determine the potential of these indicators to predict response to therapy, remission, and survival times.